Article: WATSON PHARMACEUTICALS ANNOUNCES JOINT VENTURE IN CHINA

CORONA, Calif., March 6 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (Nasdaq: WATS) today announced that its wholly-owned subsidiary, Watson Pharmaceuticals (Asia) Ltd. ("Watson (Asia)"), has agreed to form two joint ventures with China-based Changzhou No. 4 Pharmaceutical Factory ("Changzhou"). The first joint venture, Changzhou Watson Pharmaceutical Co. Ltd. ("Joint Venture A") will establish a manufacturing facility in China for the production of pharmaceuticals and related products. Joint Venture A will market and sell products in China, with products outside China being sold through Watson (Asia).

A second joint venture between Watson (Asia) and Changzhou will ...






Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!